Antonella Smeriglio | Biology | Innovative Research Award

Published on by Research Hypothesis

Innovative Research Award

Antonella Smeriglio
The University of Messina, Italy

Antonella Smeriglio
Affiliation The University of Messina
Country Italy
Scopus ID 55795057000
Documents 141
Citations 6,414
h-index 40
Subject Area Biology
Event International Research Hypothesis Excellence Award
ORCID 0000-0002-9756-304X

Antonella Smeriglio is a researcher and academic affiliated with the University of Messina in Italy whose work is situated principally within pharmaceutical biology, pharmacognosy, phytochemistry, natural products, and the biological evaluation of plant-derived compounds. University and researcher-profile sources describe research activities involving the chemical characterization of plant extracts and bioactive constituents together with antioxidant, anti-inflammatory, cytoprotective, anti-melanogenic, anti-angiogenic, and antimicrobial investigations. [1]

Abstract

The Innovative Research Award profile recognizes scholarly activity characterized by sustained investigation, methodological development, and contributions to the understanding of biologically active natural products. Antonella Smeriglio’s documented research at the University of Messina encompasses pharmaceutical biology and pharmacognosy, with particular attention to phytochemical characterization and the biological properties of plant-derived materials. [1] [2]

Keywords

Antonella Smeriglio; Innovative Research Award; University of Messina; pharmaceutical biology; pharmacognosy; phytochemistry; natural products; plant bioactive compounds; antioxidant activity; nutraceutical research; biological evaluation; research innovation.

Introduction

Research in pharmaceutical biology frequently connects the characterization of natural substances with experimental assessment of their biological effects. Within this broad field, Smeriglio’s research has focused on plant-derived extracts and isolated compounds, combining analytical approaches with cell-free, cell-based, and in vivo models. The University of Messina profile describes experience in liquid and gas chromatography, mass spectrometry, atomic absorption methods, and biological assays used to investigate properties of natural substances. [1][2]

Research Profile

Smeriglio is associated with the Department of Chemical, Biological, Pharmaceutical and Environmental Sciences at the University of Messina. The university profile identifies her research area with pharmaceutical biology and describes research lines involving phytochemical characterization and biological evaluation of plant extracts and their bioactive constituents. [1]

Independent scholarly profiles likewise associate her with pharmaceutical biology, natural product chemistry, phytochemicals, herbal medicine, pharmacology, antioxidants, polyphenols, and flavonoids. [3] Her ORCID record provides an additional persistent identifier and confirms the association between her researcher identity and Scopus Author ID 55795057000. [2]

Research Contributions

A central feature of Smeriglio’s research is the investigation of natural materials as sources of biologically relevant compounds. Her documented work examines chemical composition alongside activities such as antioxidant, cytoprotective, anti-inflammatory, anti-angiogenic, antimicrobial, and related biological effects. [1] [2]

Publications

The available scholarly records show a broad publication portfolio. The following examples illustrate representative themes rather than constituting a complete bibliography. Current indexing records may differ in document counts and citation metrics as databases are updated. [2]

Research Impact

The supplied recognition data attribute 141 documents, 6,414 citations, and an h-index of 40 to the researcher. These values should be understood as database-dependent indicators rather than fixed measures of scientific quality, because bibliometric databases are continuously updated and can report different counts at different times. For comparison, the currently accessible ScienceDirect author record associated with Scopus ID 55795057000 reports 135 documents, 5,851 citations, and an h-index of 37, demonstrating the importance of recording the source and date when presenting bibliometric metrics.[1]

Award Suitability

For the International Research Hypothesis Excellence Award, the supplied profile presents several characteristics that are relevant to an evaluation under an innovative research category. These include sustained publication activity, research spanning multiple related disciplines, development and application of analytical methodologies, and experimental investigation of biologically active natural substances. The documented institutional and ORCID records provide independently traceable information about the researcher’s academic identity and scholarly activity. [1] [2]

Conclusion

Antonella Smeriglio’s research profile reflects sustained scholarly engagement in pharmaceutical biology, pharmacognosy, phytochemistry, and the investigation of natural products. Her work combines analytical characterization with biological testing and encompasses research questions related to antioxidant, cytoprotective, anti-inflammatory, antimicrobial, nutraceutical, and other biologically relevant properties of natural substances. [1]

References

  1. Università degli Studi di Messina. (n.d.). Antonella Smeriglio — Research profile and institutional information. University of Messina.
    https://unime.unifind.cineca.it/get/person/030010
  2. ORCID. (n.d.). Antonella Smeriglio,ORCID.
    https://orcid.org/0000-0002-9756-304X
  3. ResearchGate. (n.d.). Antonella Smeriglio — University of Messina research profile.
    https://www.researchgate.net/profile/Antonella-Smeriglio
  4. Smeriglio, A., Bonasera, S., Monforte, M. T., Galati, E. M., & Trombetta, D. (2019). Opuntia ficus-indica (L.) Mill. fruit as source of betalains with antioxidant, cytoprotective, and anti-angiogenic properties. Phytotherapy Research. DOI: 10.1002/ptr.6345.
    https://doi.org/10.1002/ptr.6345
  5. Smeriglio, A., et al. (2023). Synergistic Combination of Citrus Flavanones as Strong Antioxidant and COX-Inhibitor Agent. Antioxidants, 12(4), 972. DOI: 10.3390/antiox12040972.
    https://doi.org/10.3390/antiox12040972

Shouping Xu | Biology and Life Sciences | Best Researcher Award

Published on by Research Hypothesis

Assoc. Prof. Dr. Shouping Xu | Biology and Life Sciences | Best Researcher Award

Assoc. Prof. Dr. Shouping Xu | Biology and Life Sciences | Medical Physicist | Cancer Hospital Chinese Academy of Medical Sciences | China

Assoc. Prof. Dr. Shouping Xu is a distinguished medical physicist specializing in radiation oncology, with extensive expertise in advanced radiotherapy techniques and the integration of artificial intelligence in cancer treatment. He holds degrees in nuclear physics and medical physics from leading Chinese institutions and has served in senior leadership roles as Chief Clinical Medical Physicist at the Cancer Hospital, Chinese Academy of Medical Sciences, and previously at the Chinese PLA General Hospital and Yi Zhou Proton Therapy Center. Assoc. Prof. Dr. Shouping Xu  has made significant contributions to the development of innovative dose prediction models, proton therapy planning, and image-guided radiotherapy, with numerous publications in high-impact international journals. His active engagement in global conferences, memberships in professional societies, and certifications from recognized boards reflect his commitment to advancing medical physics. Widely respected for both his clinical leadership and research excellence, Assoc. Prof. Dr. Shouping Xu continues to play a key role in shaping the future of precision radiotherapy and medical imaging technologies.

Professional Profile 

Education  

Assoc. Prof. Dr. Shouping Xu has a strong academic background in physics and medical physics, beginning with a Bachelor of Science degree in Nuclear Physics Technology from Lanzhou University, China. He went on to pursue advanced studies at Tsinghua University, where he earned a Master of Science degree in Medical Physics from the Department of Engineering Physics, followed by a Doctor of Philosophy in Medical Physics from the same department. His education provided a solid foundation in radiation physics, imaging, and advanced treatment technologies, which has been central to his career in radiation oncology and his contributions to clinical innovation and research in medical physics.

Professional Experience

Assoc. Prof. Dr. Shouping Xu has built an extensive professional career in medical physics, holding key clinical and leadership positions in some of China’s most renowned cancer treatment centers. He currently serves as Chief Clinical Medical Physicist at the Proton Center of the Cancer Hospital, Chinese Academy of Medical Sciences, where he oversees clinical operations, quality management, and research in advanced radiotherapy. Previously, he was Chief Medical Physicist and Vice Director at the Yi Zhou Proton Therapy Center, where he played a pivotal role in establishing clinical workflows and implementing cutting-edge proton and photon therapies. Earlier in his career, he served at the Chinese PLA General Hospital as Chief and Senior Medical Physicist, contributing to innovations in IMRT, image-guided radiotherapy, and quality assurance. With responsibilities ranging from managing multidisciplinary teams to developing clinical protocols and engaging in pioneering research, Assoc. Prof. Dr. Shouping Xu has consistently demonstrated leadership, technical expertise, and a strong commitment to advancing radiation oncology practices.

Research Interest

Assoc. Prof. Dr. Shouping Xu’s research interests lie at the intersection of medical physics, radiation oncology, and artificial intelligence, with a focus on advancing precision radiotherapy. His work emphasizes the development of AI-driven algorithms and deep learning models for dose prediction, treatment planning, and image-guided radiotherapy, aiming to improve both the efficiency and accuracy of cancer treatment. He has conducted extensive studies on proton therapy, CyberKnife radiosurgery, and advanced techniques such as VMAT, IMRT, and adaptive radiotherapy, contributing to innovations in treatment optimization and quality assurance. Additionally, his research explores deformable image registration, dose verification, and the clinical application of AI for enhancing radiotherapy workflows. By bridging physics, engineering, and oncology, Assoc. Prof. Dr. Shouping Xu is committed to translating cutting-edge technologies into practical clinical tools that improve outcomes and safety for cancer patients.

Award and Honor

Assoc. Prof. Dr. Shouping Xu has earned recognition for his significant contributions to medical physics and radiation oncology through his active involvement in international conferences, professional societies, and research achievements. He has been an invited speaker and presenter at prestigious forums such as the AAPM Annual Meetings, the IUPESM World Congress on Medical Physics and Biomedical Engineering, and the Asia-Oceania Congress of Medical Physics, where his work on advanced radiotherapy techniques and AI-driven innovations has been highlighted. His leadership roles as Chief Clinical Medical Physicist and his certifications from the Chinese Board of Medical Physicists (CBMP) and the Chinese Board of Radiation Protection (CBRP) further underscore his professional excellence. Through his research, publications, and professional service, Assoc. Prof. Dr. Shouping Xu has gained both national and international recognition, reflecting his status as a highly respected figure in the field of medical physics.

Publications Top Noted

Dosimetric evaluation of intensity modulated proton therapy and photon volumetric modulated arc therapy for bilateral breast cancer
Year: 2025

Virtual-simulation boosted neural network dose calculation engine for intensity-modulated radiation therapy
Year: 2025

Dose rate correction of a diode array for universal wedge field dosimetric verification
Year: 2025

gMCAP: a GPU-based Monte Carlo proton transport program for high-density tissues with precise nuclear reaction models
Year: 2025

An AI dose-influence matrix engine for robust pencil beam scanning protons therapy
Year: 2025

A feasibility study of dose-band prediction in radiation therapy: Predicting a spectrum of plan dose
Year: 2025

A StarGAN and transformer-based hybrid classification-regression model for multi-institution VMAT patient-specific quality assurance
Year: 2025

Dose prediction of CyberKnife Monte Carlo plan for lung cancer patients based on deep learning: robust learning of variable beam configurations
Year: 2024

Dosimetric comparison of ZAP-X, Gamma Knife, and CyberKnife stereotactic radiosurgery for single brain metastasis
Year: 2024

Conclusion

Assoc. Prof. Dr. Shouping Xu is highly suitable for the Best Researcher Award. His combination of clinical leadership, innovative research in AI-driven radiation therapy, and active participation in international scientific forums positions him as a thought leader in medical physics and oncology. With his strong portfolio of publications and pioneering approaches to radiation therapy planning and quality assurance, he demonstrates both scientific excellence and clinical relevance. With further emphasis on international collaborations and translational outcomes, his contributions will continue to shape the future of precision radiotherapy.